Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixempra in Stage IV Melanoma
NCT00036764Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2002
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in Malignant Melanoma (MM), sponsored by National Cancer Institute. Started Feb 2002; status: completed.
02
Drugs
ixabepilone
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00036764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036764.